Bristol-Myers Joins Big Pharma Attack On Price Negotiating
By Hailey Konnath · June 16, 2023, 11:25 PM EDT
Bristol-Myers Squibb Co. on Friday lobbed yet another challenge to landmark legislation allowing Medicare to negotiate drug prices, slamming the law as unconstitutional and not actually involving negotiations "in any ordinary...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login